Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Moodys
Baxter
Dow
McKesson

Last Updated: August 19, 2022

Investigational Drug Information for Tesetaxel


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Tesetaxel?

Tesetaxel is an investigational drug.

There have been 16 clinical trials for Tesetaxel. The most recent clinical trial was a Phase 2 trial, which was initiated on December 21st 2017.

The most common disease conditions in clinical trials are Breast Neoplasms, Stomach Neoplasms, and Neoplasms. The leading clinical trial sponsors are Genta Incorporated, Odonate Therapeutics, Inc., and M.D. Anderson Cancer Center.

There are six hundred and sixty-five US patents protecting this investigational drug and six international patents.

Recent Clinical Trials for Tesetaxel
TitleSponsorPhase
The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid TumorsOdonate Therapeutics, Inc.Phase 1
Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBCOdonate Therapeutics, Inc.Phase 2
Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBCOdonate Therapeutics, Inc.Phase 2

See all Tesetaxel clinical trials

Clinical Trial Summary for Tesetaxel

Top disease conditions for Tesetaxel
Top clinical trial sponsors for Tesetaxel

See all Tesetaxel clinical trials

US Patents for Tesetaxel

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Tesetaxel See Plans and Pricing Heat shock protein 70 (hsp-70) receptor ligands Duke University (Durham, NC) See Plans and Pricing
Tesetaxel See Plans and Pricing Compounds and their methods of use Agios Pharmaceuticals, Inc. (Cambridge, MA) See Plans and Pricing
Tesetaxel See Plans and Pricing Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use Chugai Seiyaku Kabushiki Kaisha (Tokyo, JP) See Plans and Pricing
Tesetaxel See Plans and Pricing Pyrrolidinone derivatives as MetAP-2 inhibitors Merck Patent GmbH (Darmstadt, DE) See Plans and Pricing
Tesetaxel See Plans and Pricing Method of reducing blood glucose by administering RON agonists GENENTECH, INC. (South San Francisco, CA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Tesetaxel

Drugname Country Document Number Estimated Expiration Related US Patent
Tesetaxel World Intellectual Property Organization (WIPO) WO2015148714 2034-03-25 See Plans and Pricing
Tesetaxel Australia AU2015231053 2034-03-21 See Plans and Pricing
Tesetaxel Brazil BR112016021620 2034-03-21 See Plans and Pricing
Tesetaxel Canada CA2943339 2034-03-21 See Plans and Pricing
Tesetaxel China CN106231900 2034-03-21 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Moodys
Baxter
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.